Back to Search
Start Over
Event Brief of Q4 2023 Eli Lilly and Co Earnings Call - Final
- Source :
- Fair Disclosure Wire. February 6, 2024
- Publication Year :
- 2024
-
Abstract
- CORPORATE PARTICIPANTS . Anat Ashkenazi - Eli Lilly and Company,Executive VP & CFO . Daniel M. Skovronsky - Eli Lilly and Company,EVP, Chief Scientific Officer and President of Lilly Research [...]
- Subjects :
- United States. Food and Drug Administration -- Conferences, meetings and seminars
Eli Lilly and Co. -- Conferences, meetings and seminars
Lilly Research Laboratories -- Conferences, meetings and seminars
Business
Jardiance (Medication)
Trulicity (Medication)
Verzenio (Medication)
Mounjaro (Medication)
Zepbound (Medication)
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Fair Disclosure Wire
- Publication Type :
- Transcript
- Accession number :
- edsgcl.783282672